News

Dr. Reddy’s Laboratories records $2.2 billion in annual sales, up 14%

BY Michael Johnsen

HYDERABAD, India — Dr. Reddy’s Laboratories on Tuesday posted $2.2 billion in annual sales for the fiscal year ended March 31, representing growth of 14%.

The company launched 54 new generic products and filed 51 new product registrations and 61 Drug Master Files globally in fiscal year 2014.

Revenues from the company’s global generics segment totaled $1.8 billion, with year-on-year growth of 27%, primarily driven by North America and emerging markets. Revenues from North America for fiscal year 2014 totaled more than $900 million with year-on-year growth of 46%. Growth was largely driven by key launches with limited competition. Nine new products were launched during the year, including azacitidine, decitabine, zoledronic acid, donepezil 23mg and divalproex ER.

Cumulatively, Dr. Reddy’s Laboratories has 62 ANDAs pending for approval with the Food and Drug Administration, of which 39 are Paragraph IVs, out of which nine have ‘First To File’ status.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Joey New York acquires Joey New York brand of beauty products

BY Antoinette Alexander

SUNNY ISLES, Fla. — Joey New York has acquired the Joey New York brand of skin care and beauty products through its acquisition of RAR Beauty.

"The Joey New York brand will now have expanded access to the capital needed to develop once again into a significant brand in the skin care, cosmetics and personal care industry; not only through organic growth, but also through strategic acquisitions of companies in which we can integrate into the Joey New York brand business model," stated Richard Roer, president of Joey New York.

In the early 1990s, the Joey New York brand pioneered the "instant visible results spa at home concept," and produced products that were deemed "the safe alternatives to painful, costly dermatological procedures,” the company stated. Founder Joey Chancis has worked to reinvent the Joey New York brand.

"We believe this acquisition marks a significant event in the renewed growth of the Joey New York brand by providing new opportunities for us to expand our current product assortment, as well as develop additional skin care and cosmetic products for multi-channel distribution. We strive to accommodate the consumer demand for high quality beauty products, affordable prices and fast acting formulas. These markets include prestige, masstige, mass and health/wellness stores both domestically and internationally. I want to express my gratitude to my loyal customers who, for over two decades, have believed in me and my products, and I look forward to sharing more exciting products with you in the future," Chancis said.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

American College of Physicians and partners seek to improve immunization rates

BY Michael Johnsen

PHILADELPHIA — The American College of Physicians, CECity and Pfizer on Wednesday announced a new initiative designed to increase adult immunization rates. 

"As a national organization of internists, ACP’s internal medicine physician specialists and their practice teams play a critical role in increasing adult immunization rates," stated Robert Centor, chair of ACP’s Board of Regents, and a practicing internist. "Recommending and offering appropriate vaccinations is a core component of preventive health care, leading to improved public health, less suffering and fewer deaths from preventable illnesses, and lower healthcare costs."

The goal of this public health initiative is to meet the National Vaccine Advisory Committee’s standards for adult immunization. The standards call on all healthcare providers to assess vaccine status at each visit, strongly recommend vaccinations to patients, administer or refer for immunization and document vaccination. Current vaccination rates for recommended vaccines in the United States fall far short of those goals, with all rates well below 70%. 

"Pfizer is working to raise immunization rates to help protect against vaccine preventable diseases," said Freda Lewis-Hall, EVP and chief medical officer for Pfizer. "By bringing together tremendous expertise in health care, technology and quality improvement, this collaboration can make great strides to address the long-standing public health challenge of vaccinating American adults."

Research shows that a physician recommendation is the strongest predictor of vaccination, the coalition noted. Although the tracking and improvement of adult immunization rates has been encouraged through guidelines and multiple incentives programs, including the meaningful use of electronic health records, most physicians currently do not have the information they need to close the gap and increase the number of patients vaccinated.

A national advisory group co-chaired by Bernard Rosof, CEO of QHC Advisory Group and William Schaffner, immediate past-president of the National Foundation for Infectious Diseases, will oversee the program, which will incorporate documented strategies for increasing adult immunization rates and existing ACP resources.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?